GlassScriptPhysician profile
Melissa Hogan
NPI 1023475688
$4,174.55
in general payments reported to CMS, 2019-2025
14 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $89.29 · 2023: $923 · 2024: $1,205 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,946 · Education: $3.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,945.59 |
| Education | $3.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,061.10 | 2021-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Indivior INC. | $645.97 | 2023-2025 | Sublocade, Perseris |
| Alkermes, INC. | $444.24 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $416.92 | 2023-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $363.31 | 2024-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $310.44 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $280.78 | 2023-2025 | Caplyta |
| Lundbeck LLC | $182.84 | 2023-2025 | Rexulti |
| Abbvie INC. | $166.00 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $158.86 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $85.18 | 2023-2024 | Auvelity |
| Pear Therapeutics (US), INC. | $24.07 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.56 | 2025 | Uzedy |
| Noven Therapeutics, LLC | $16.28 | 2023 | Secuado, Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.